SGLT2 inhibitors in type 1 diabetes: knocked down, but up again?

Petrie, J. R. (2017) SGLT2 inhibitors in type 1 diabetes: knocked down, but up again? Lancet Diabetes and Endocrinology, 5(11), pp. 841-843. (doi:10.1016/S2213-8587(17)30315-7) (PMID:28919060)

[img]
Preview
Text
148441.pdf - Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

408kB

Abstract

No abstract available.

Item Type:Articles (Editorial)
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Petrie, Professor John
Authors: Petrie, J. R.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
Journal Name:Lancet Diabetes and Endocrinology
Publisher:Elsevier
ISSN:2213-8587
ISSN (Online):2213-8595
Published Online:14 September 2017
Copyright Holders:Copyright © 2017 Elsevier Ltd.
First Published:First published in Lancet Diabetes and Endocrinology 5(11): 841-843
Publisher Policy:Reproduced with the permission of the Editor

University Staff: Request a correction | Enlighten Editors: Update this record